Decoding the Stressed Brain: How Oxidative Stress Manifests in qEEG Patterns

Introduction: The Invisible Toll of Stress on the Brain

Stress is an undeniable constant in modern existence. We feel its pressure in deadlines, traffic jams, and the relentless pace of daily life. But while the feeling of stress is subjective, its impact on our biology, particularly within the intricate electrical symphony of the brain, is increasingly measurable. Beyond the immediate sensations of anxiety, chronic stress exerts a hidden physiological toll, leaving biological footprints that can be objectively observed and understood.

One of the primary sources of strain on the brain is oxidative stress. Simply put, oxidative stress begins when an imbalance occurs between the production of damaging molecules called and the body’s ability to neutralize them with antioxidants. The brain’s high energy demands and rich lipid content make it particularly vulnerable to this type of damage, which can be significant—oxidative stress is implicated in the development and progression of numerous neurological conditions, including neurodegenerative diseases like Alzheimer’s and Parkinson’s, as well as the aging process itself. 

Fortunately, we now have tools that offer a non-invasive window into the brain’s functional state: Quantitative Electroencephalography (qEEG). QEEG analyzes the brain’s electrical activity, recorded via electrodes placed on the scalp, providing detailed information about underlying neural rhythms. You can learn more about qEEG brain mapping on NewMind’s site. Basically, your brain produces different types of electrical waves, known as Delta, Theta, Alpha, Beta, and Gamma, which show how groups of your brain cells are communicating. In fact, the patterns they form can tell us about your mental and emotional states, and can also point to possible neurological dysfunction.

Against this backdrop, Dr. Richard Soutar, cofounder of NewMind Technologies, offers an important contribution. In his 2016 presentation, “Oxidative Stress & qEEG Patterns,” Dr. Soutar outlines a model suggesting that oxidative stress leaves discernible fingerprints on the brain’s electrical activity. As oxidative burden increases, these changes unfold in systematic and recognizable stages—patterns that qEEG analysis can reveal.

Accordingly, examining Dr. Soutar’s proposed stages alongside broader scientific research provides a valuable framework for interpreting the neurological consequences of oxidative stress. For clinicians—particularly those practicing functional neurofeedback—this model offers a structured lens through which to assess brain function and design targeted interventions that support recovery and resilience.

To fully contextualize Dr. Soutar’s model, this post will first examine the biological foundations of oxidative stress, analyze how his proposed qEEG stages correspond with current scientific knowledge, and investigate the broader physiological impact of chronic stress on brain function. We will conclude by considering the potential applications for neurofeedback interventions.

The Science of Oxidative Stress: When Cellular Balance Tips

Oxidative stress arises when the generation of ROS and related reactive nitrogen species (RNS) overwhelms the body’s antioxidant defense systems. These reactive molecules, often byproducts of normal metabolism, can damage vital cellular components, including lipids (fats), proteins, and DNA if left unchecked. Mitochondria, the powerhouses of our cells, are a primary source of ROS, particularly relevant for the brain due to its immense energy requirements and reliance on aerobic respiration. This constant metabolic activity makes brain tissue inherently susceptible to oxidative damage.

Rather than occurring independently, oxidative stress and neuroinflammation are dynamically, bidirectionally linked, together driving a cycle of cumulative damage within the brain: oxidative stress can trigger inflammatory responses in the brain, such as the activation of glial cells (the brain’s immune cells), which in turn produce more ROS and inflammatory cytokines. Conversely, inflammation itself generates oxidative stress. This reciprocal interaction between oxidative stress and neuroinflammation fuels a self-perpetuating cycle of neuronal damage, frequently observed across chronic neurodegenerative conditions.

What contributes to this damaging imbalance? While internal metabolic processes play a role, several external factors can significantly increase the oxidative load. Chronic psychological stress is a major contributor. Environmental toxins, including heavy metals like aluminum—whose neurotoxicity involves promoting oxidative stress and inflammation—are also implicated (Yokel 2000). Other factors include poor diet, inadequate sleep, infections, and excessive physical exertion.

The brain’s unique composition further amplifies its risk from oxidative stress. It contains a large amount of fatty materials that are easily harmed by unstable molecules like ROS and also uses a lot of oxygen to meet its high energy demands, which can produce even more of these harmful molecules. Unlike other organs, such as the liver, the brain has fewer natural defenses against this kind of damage, leaving it at greater risk over time.

Considering the wide range of conditions linked to oxidative stress and neuroinflammation – from general neurodegeneration and specific diseases like Alzheimer’s and Parkinson’s to cognitive decline, the consequences of traumatic brain injury, and even the effects of toxins like aluminum – a compelling picture emerges. Oxidative stress seems to act like a shared pathway that different types of damage, whether from emotional stress, environmental toxins, or physical injuries, all travel through to harm the brain. If very different problems trigger the same type of stress and inflammation in the brain, it means we may be able to track these issues by looking for specific signs, such as patterns found in qEEG brain scans. It also means that treatments focused on reducing oxidative stress might have the potential to help a wide variety of brain-related problems.

Mapping the Stress Response: Dr. Soutar’s qEEG Stages of Oxidative Stress

Drawing from clinical observations correlating qEEG patterns with patient symptoms and potential underlying physiology, Dr. Richard Soutar developed a model showing how the brain’s electrical activity changes as oxidative stress builds up. In his talk, he outlines a series of stages that can be seen through qEEG brain mapping. This model isn’t meant to be a strict diagnosis, but rather a tool to help make sense of how stress might be affecting the brain’s function over time.

Stage 1: Acute Stress / Alarm Phase (“Fight or Flight”)

• Description: This initial stage mirrors the classic “fight or flight” response. It’s characterized by activation of the sympathetic nervous system, leading to feelings of anxiety, hypervigilance, restlessness, difficulty relaxing, and potentially panic attacks. In his model, Dr. Soutar associates this phase with a “fast oxidizer” metabolic profile.
• QEEG Signature: In this stage, the brain often shows a specific pattern called Beta asymmetry, where faster Beta brainwaves (about 13–30 Hz) are stronger on the right side of the brain than the left. This “signature” pattern is typically seen in the frontal and temporal brain regions. There may also be an overall increase in Beta activity across the scalp.
• Scientific Support: Research strongly backs the idea that the brainwave patterns seen in this stage—especially Beta asymmetry—are linked to feelings of anxiety and stress.
  • Studies show that the balance of brain activity between the left and right hemispheres plays an important role in emotional regulation. For instance, Davidson’s model explains that more activity on the left side of the brain tends to support positive emotions and motivation, while more activity on the right side is linked to negative emotions like fear, worry, and withdrawal behaviors. In fact, multiple studies have found that people with greater right-sided Beta brainwave activity—or less Alpha activity in the right hemisphere—are more likely to experience anxiety (Soutar 2013).
  • Research also shows that increased right frontal activity is connected to heightened vigilance toward threats. This fits with the hyper-alertness and emotional reactivity that often surface in the early stages of stress.
  • In general, Beta waves are associated with focused thinking, alertness, and mental effort. When Beta activity ramps up too much, especially on the right side, it can signal that the brain is stuck in a high-alert, high-energy mode. Some studies suggest that when Beta waves are unusually strong, it reflects not just mental overdrive but also greater metabolic strain on the brain, meaning it’s working harder than necessary and may be less efficient.

Researchers often distinguish between short-term (or “state”) changes in brain activity and more lasting (or “trait”) patterns. This difference matters when we look at Stage 1 of oxidative stress. In the early stages of stress, the Beta asymmetry we see on a qEEG may simply reflect the brain’s immediate, temporary response to a stressful event—what’s known as an acute sympathetic reaction.

However, if stress continues over time without relief, the brain’s patterns can start to shift. What began as a temporary response can become more permanent, locking in a “trait” of anxious arousal and withdrawal. In other words, the brain adapts to being in a constant state of alertness.

This is important because it shows that qEEG doesn’t just capture momentary reactions—it can also reveal deeper, longer-term changes in how the brain is functioning. Being able to recognize these shifts gives clinicians valuable insight into how stress is affecting the brain over time and how early interventions might prevent more serious problems later

Stage 2: Chronic Stress / Resistance Phase (“Wearing Down”)

• Description: As stress persists, the body enters a resistance phase, attempting to adapt. The HPA axis often remains chronically activated. This stage is associated with symptoms like fatigue, difficulty concentrating (“brain fog”), decreased motivation, emerging depressive symptoms, and a feeling of being worn down. Dr. Soutar links this to a shift towards a “slow oxidizer” metabolic profile, reflecting a potential exhaustion of the initial stress response systems.
• QEEG Signature: This stage is marked by a shift towards slower brainwave activity compared to Stage 1. Key features may include:

• • Increased Alpha power (8-12 Hz), potentially with asymmetry (notably, increased Alpha in the left frontal region is a well-known correlate of depression).
  • Increased Theta power (4-8 Hz).
  • Reduced overall Beta power or a slowing of the dominant Beta frequency.
  • Possible decrease in the peak frequency of Alpha rhythm.

• Scientific Support: The changes we see in the brain during this stage of stress are well-supported by research. They match what we often find in people dealing with long-term stress, fatigue, and even depression.

• • Alpha Changes: Normally, Alpha brainwaves (8–12 Hz) are strongest when you’re calm but awake, like during quiet rest. In the early stages of stress, Alpha activity often drops as the brain ramps up. But when stress becomes chronic, the pattern shifts. Studies show that chronic stress and fatigue can actually cause Alpha activity to increase—especially on the left side of the brain’s frontal lobe. This imbalance, called Alpha asymmetry, is often linked to feelings of withdrawal, sadness, and low motivation. Disruptions in sleep patterns, like reduced deep sleep and disturbed REM sleep, are also common in people with depression and mirror this brainwave shift. In some cases, too little Alpha activity may be seen instead, especially in early stages of cognitive decline.
  • Theta Increase:Theta waves (4–8 Hz) are perfectly normal during light sleep or deep relaxation. But when they start showing up more often while you’re awake, it can signal trouble. Increased Theta activity during waking hours often points to problems with attention, memory, and mental sharpness. Studies have found that people experiencing early signs of cognitive decline, including Alzheimer’s disease, tend to have more Theta wave activity. A high ratio of Theta to Beta waves has also been linked to poor focus and inefficient brain processing.
  • Beta Reduction/Slowing: Beta waves (13–30 Hz) are typically linked to active thinking, problem-solving, and alertness. In Stage 1 of stress, Beta activity may be too high. But over time, as stress wears the brain down, Beta activity tends to drop. A decrease in Beta is common in states of mental fatigue, low energy, and cognitive sluggishness. Interestingly, while some people with depression might still show bursts of Beta activity, they often struggle to activate the right brain networks during tasks, suggesting deeper issues with brain flexibility and energy regulation
  • General Slowing: As chronic stress takes a heavier toll, the brain may start showing more slow-wave activity (Theta and Delta waves) even during wakefulness. This general “slowing” is a red flag and is seen in a variety of serious conditions, such as brain injuries, metabolic problems, and neurodegenerative diseases like Alzheimer’s.
  • All these changes paint a clear picture: when stress becomes chronic, the brain doesn’t just feel tired—it functions differently. Brainwaves start to slow down, energy levels drop, and emotional resilience weakens. Understanding these shifts through qEEG can help clinicians recognize the deeper impact of stress early and tailor more effective interventions.

The interpretation of Alpha activity changes requires careful consideration of context. An increase in Alpha power isn’t inherently positive or negative; it can signify relaxation and calmness, but in the context of Stage 2, it might also reflect the onset of depressive hypoactivation (especially if localized to the left frontal area) or cognitive slowing and inefficiency associated with fatigue. Differentiating these possibilities necessitates a nuanced qEEG analysis that considers the precise location (topography), frequency characteristics (e.g., peak frequency), and asymmetry of the Alpha activity, rather than just its overall power.

Stage 3: Exhaustion / Neuroinflammation Phase (“System Breakdown”)

• Description: This stage represents a state of physiological exhaustion where the body’s adaptive mechanisms are overwhelmed. It’s characterized by significant cellular damage, pronounced neuroinflammation, and potentially the beginnings of neurodegenerative processes. Symptoms include severe fatigue, burnout, significant cognitive decline (memory problems, poor executive function), and potentially increased vulnerability to illness. Dr. Soutar also mentions the possible role of accumulated toxins, like heavy metals, contributing to the overall burden at this stage.
• QEEG Signature: The hallmark of this stage is the predominance of slow wave activity (Delta: 1-4 Hz and Theta: 4-8 Hz) during the waking state. Other features include:

• • Significant reduction in faster frequencies (Alpha and Beta)
  • Low overall voltage or power across the scalp
  • Potential for focal slowing (slow waves concentrated in specific brain regions), indicating localized areas of dysfunction
  • Possible alterations in brain connectivity patterns (e.g., decreased coherence in certain bands, though connectivity changes can be complex)

• Scientific Support: Widespread slow wave activity during wakefulness is a well-established marker of significant brain dysfunction across numerous conditions.

• • Delta/Theta Excess: Normally, slower brainwaves like Delta (1–4 Hz) and Theta (4–8 Hz) are strongest during deep sleep or very relaxed states. However, when someone is awake and these slow waves dominate, it often signals that something is wrong. Conditions like dementia (including Alzheimer’s and Lewy Body Dementia), serious brain injuries (TBI), strokes, and even certain metabolic problems often show this pattern Medscape EEG in Dementia). In fact, a rise in Delta and Theta activity is one of the clearest early signs of cognitive decline, especially in Alzheimer’s disease
  • Reduced Fast Waves: As these slower waves (Delta and Theta) become stronger, the faster waves—Alpha (8–12 Hz) and Beta (13–30 Hz)—often weaken. This matters because Alpha and Beta waves are connected to things like attention, mental energy, and flexible thinking. When their power drops, it suggests that the brain isn’t staying active and responsive the way it normally should. In scientific terms, this is sometimes called reduced cortical activation—meaning the brain’s outer layer (the cortex), responsible for higher-level thinking and decision-making, isn’t firing as often or as efficiently as it should. In severe cases, this slowdown can become so extreme that the brain’s electrical signals drop to very low levels, something seen in advanced neurodegenerative diseases like Huntington’s disease.
  • Neuroinflammation Connection: Even though a qEEG can’t measure inflammation directly, there’s strong evidence that when we see this kind of slow-wave dominance, the brain is often under attack from hidden inflammation and oxidative stress. Diseases like dementia, serious brain injuries, and metabolic conditions typically involve both. The pattern of excessive slow waves likely reflects the brain struggling with this ongoing inflammatory damage. This helps explain why factors like toxin exposure—including to metals like aluminum—can worsen these patterns. Aluminum toxicity is known to promote both oxidative stress and brain inflammation, making it a contributor to problems like those seen in Alzheimer’s disease.

These stages described by Dr. Soutar outline a gradual decline in brain function under ongoing stress. In the beginning (Stage 1), the brain is in a state of high alert—what’s called hyper-arousal—and shows signs of imbalance between its left and right hemispheres. As stress continues (Stage 2), the brain tries to adapt, but signs of strain start to appear: mental fog, fatigue, and shifts in brainwave activity that suggest it’s not processing information as efficiently. By the final stage (Stage 3), the brain’s activity has slowed dramatically. It’s no longer able to maintain the fast, healthy rhythms we expect during normal wakefulness. This slowdown points to serious wear and tear—reduced energy use in the brain, poor communication between neurons, and likely long-term effects from oxidative stress and inflammation. At this stage, brain function is clearly impaired, and it becomes much harder for the brain to bounce back. That’s why spotting these patterns early with qEEG is so valuable—it can pick up signs of trouble before more obvious symptoms or structural brain changes appear.

Stages of Oxidative Stress in the Brain: qEEG and Physiological Correlates

Stage	Associated State	Key QEEG Signatures	Potential Underlying Physiology	Supporting Research Concepts (Examples)
1	Acute Stress / Alarm	Right > Left Beta Asymmetry; Increased overall Beta	Sympathetic Nervous System Dominance; Amygdala Hyperactivity; High Arousal	Asymmetry models
2	Chronic Stress / Resistance	Increased Alpha (esp. Left Frontal); Increased Theta; Reduced Beta	HPA Axis Adaptation/Dysregulation; PFC/Hippocampal Strain; Fatigue; Emerging Depression/Anxiety	Alpha & Depression/Stress ; Theta Increase ; Slowing
3	Exhaustion / Neuroinflam.	Dominant Delta/Theta; Reduced Alpha/Beta; Low Voltage	Severe Oxidative Stress/Neuroinflammation; Metabolic Compromise; Neuronal Dysfunction/Damage	Pathological Slowing Slowing in TBI/Dementia OS/Inflammation Links

 

The Physiological Underpinnings: Chronic Stress and Brain Structures

To fully appreciate how these qEEG patterns might arise, it’s essential to understand the physiological impact of chronic stress on the brain’s core regulatory systems and structures. The Hypothalamic-Pituitary-Adrenal (HPA) axis is central to this process. In response to perceived stress, the hypothalamus releases corticotropin-releasing hormone (CRH), signaling the pituitary gland to secrete adrenocorticotropic hormone (ACTH). ACTH then travels to the adrenal glands, prompting the release of cortisol (a primary stress hormone). Cortisol helps mobilize energy and adapt to the stressor but is meant to be a short-term response.

Under conditions of chronic stress, this system often becomes dysregulated. Many individuals experience HPA axis hyperactivity, where cortisol levels remain elevated for prolonged periods. Furthermore, the negative feedback mechanisms, where cortisol normally signals the hypothalamus and pituitary to dampen the stress response, can become impaired. This results in the brain and body being bathed in excessive levels of stress hormones over long durations.

This sustained neuroendocrine pressure takes a toll on specific brain structures crucial for emotion regulation, memory, and executive function – the very areas involved in controlling the HPA axis itself:

• Amygdala: Known as the brain’s “fear center,” the amygdala becomes hyperactive under chronic stress (Yale University n.d.). This heightened activity contributes to increased anxiety, fear responses, and vigilance. Some research suggests chronic stress can even lead to structural changes like increased dendritic branching in parts of the amygdala, potentially making individuals more sensitive to future stressors. This amygdala hyperactivity likely contributes significantly to the right-hemisphere dominance and beta asymmetry patterns proposed for Stage 1 of Dr. Soutar’s model.
• Hippocampus: This structure is vital for learning, memory formation, and, importantly, inhibiting the HPA axis (McEwen 2016) and is particularly vulnerable to the effects of chronic stress and excess cortisol. Prolonged stress exposure can lead to reduced neurogenesis (the birth of new neurons), dendritic atrophy (shrinking of neuronal branches), and an overall decrease in hippocampal volume. These changes impair memory consolidation and retrieval (contributing to the “brain fog” of Stage 2/3) and weaken the hippocampus’s ability to provide negative feedback to the HPA axis, thus perpetuating the cycle of stress.
• Prefrontal Cortex (PFC): Located at the front of the brain, the PFC is responsible for higher-order executive functions like planning, decision-making, working memory, attention, and emotional regulation. It also plays a role in inhibiting the HPA axis (McEwen 2016). Chronic stress impairs PFC function, leading to difficulties with concentration, problem-solving, and managing emotions. Structurally, chronic stress can cause dendritic retraction and reduced synaptic connectivity, sometimes resulting in decreased PFC volume. This impairment manifests clinically in the cognitive deficits and emotional dysregulation seen in Stages 2 and 3, and its weakened inhibitory control over the stress response further contributes to HPA axis dysregulation.

These changes in the amygdala, hippocampus, and prefrontal cortex help explain why we see certain patterns in brainwave activity (qEEG) during different stages of stress. For example, the heightened activity in the amygdala lines up with the increased right-side beta activity seen in Stage 1, which reflects anxiety and hyper-alertness. As stress wears on, problems with memory, focus, and mood start to appear—mirroring the effects of stress on the hippocampus and prefrontal cortex seen in Stage 2. By the time we reach Stage 3, where brain activity slows dramatically, it often signals more serious damage and reduced brain function. These patterns aren’t just theoretical—they’re visible in real brain data. In this way, qEEG provides a meaningful view into how chronic stress affects brain health over time.

Neurofeedback: Tuning the Stressed Brain

Understanding the brainwave patterns linked to different stages of oxidative stress—based on Dr. Soutar’s model and supported by broader research—can help neurofeedback practitioners get a deeper view of what’s happening inside the brain. Rather than just focusing on surface-level symptoms, qEEG brain mapping offers a visual and measurable look at how the brain may be functioning under stress. These patterns can reveal where and how brain activity has shifted, making it easier to design neurofeedback sessions that are tailored to the individual’s specific needs.

Neurofeedback is built on the idea of neuroplasticity—the brain’s ability to adapt and rewire itself. By giving the brain real-time feedback on its activity, neurofeedback helps encourage healthier, more balanced patterns. The types of brain activity that need to be trained or adjusted often depend on what stage of stress a person appears to be in, as revealed by their qEEG map.

• Addressing Stage 1 Patterns: For individuals exhibiting excessive right-hemisphere Beta or pronounced Beta asymmetry associated with anxiety and hyper-arousal, protocols might focus on:

• Down-training excessive Beta activity, particularly in the right hemisphere.
• Up-training calming Alpha rhythms, perhaps focusing on left-hemisphere sites associated with approach motivation and positive affect to counterbalance the withdrawal pattern.
• Training coherence or other connectivity metrics aimed at improving communication between relevant brain regions.

• Addressing Stage 2 Patterns: When qEEG shows signs of chronic strain, such as excessive slow waves (Theta), depressive patterns (e.g., increased left frontal Alpha), or reduced Beta associated with fatigue and brain fog, protocols might target:

• Inhibiting excessive Theta activity to improve alertness and focus.
• Balancing Alpha asymmetry, potentially by encouraging relatively more activity (less Alpha) on the left side compared to the right.
• Carefully up-training Beta activity in appropriate regions to enhance cognitive processing speed and alertness, monitoring carefully to avoid inducing anxiety.
• Training Alpha peak frequency upwards if it has slowed significantly.

• Addressing Stage 3 Patterns: In cases presenting with dominant slow-wave activity (Delta and Theta) indicative of severe exhaustion and potential neuroinflammation or cognitive decline, neurofeedback becomes a more complex undertaking, often as part of a comprehensive treatment plan. Goals might include:

• Gently inhibiting excessive Delta and Theta activity during wakefulness.
• Carefully encouraging the emergence of faster frequencies (Alpha and Beta) to improve cortical activation and function.
• Focusing on improving overall brain regulation and stability.
• Supporting cognitive function, drawing on evidence suggesting neurofeedback may benefit individuals with Mild Cognitive Impairment (MCI) or early dementia.

Sophisticated qEEG analysis software and comprehensive databases are invaluable tools in this process. They enable practitioners to accurately identify these complex patterns, compare individual brain maps to normative data, and develop targeted, individualized neurofeedback protocols designed to address the specific deviations observed.

It is also important to recognize that neurofeedback is typically most effective when integrated into a holistic  or “functional” approach. Addressing the root causes of oxidative stress through lifestyle modifications – such as dietary changes rich in antioxidants, regular exercise, stress management techniques, improving sleep hygiene, and minimizing toxin exposure – complements the brain training efforts of neurofeedback, creating a synergistic effect for promoting lasting brain health and resilience.

From Stress Signatures to Brain Resilience

The journey through the stages of oxidative stress, as reflected in the brain’s electrical activity, underscores a critical message: chronic stress is not just a feeling; it’s a physiological process with tangible neurological consequences. Oxidative stress and the ensuing neuroinflammation can disrupt brain function in ways that leave detectable signatures in qEEG patterns. Dr. Richard Soutar’s clinical model, proposing distinct qEEG correlates for acute stress, chronic adaptation, and eventual exhaustion, offers a valuable framework for interpreting these signatures, particularly when contextualized within the broader landscape of neuroscientific research.

What’s more, qEEG emerges as a powerful, objective tool in this context. It allows clinicians to look beneath the surface of subjective symptoms and assess the functional state of the brain, revealing patterns associated with anxiety, depression, cognitive slowing, and severe neuronal dysfunction linked to the cumulative impact of stress.

However, the story doesn’t end with identifying dysfunction. The true potential lies in leveraging the brain’s inherent capacity for change – neuroplasticity. While Stage 3 represents a state of significant challenge, the earlier stages identified through qEEG present crucial windows for intervention. Neurofeedback, guided by precise qEEG analysis like that facilitated by advanced platforms, offers a way to actively engage this neuroplastic potential. It moves beyond simply managing symptoms; it aims to help the brain learn healthier patterns of activity, potentially rewiring maladaptive stress responses, enhancing regulatory capacity, and building resilience. In this way, the goal shifts towards proactive brain health management – intervening early to potentially slow or even prevent the progression towards debilitating states of burnout, chronic fatigue, or cognitive decline.

By considering the deeper physiological states potentially reflected in qEEG patterns – the interplay of oxidative stress, neuroinflammation, HPA axis function, and structural integrity – practitioners can utilize this technology not just as a diagnostic aid, but as a guide for fostering brain resilience and optimizing neurological function in the face of life’s inevitable stressors.

Are your clients suffering from brain fog or other signs of early cognitive decline? 

If you’re ready to understand your clients’ brain function with greater precision—and use advanced qEEG analysis to create more effective, targeted interventions—NewMind Technologies is here to support you.

Discover how our tools and expertise can help you deliver even better outcomes.

 

---

Works Cited

Allen, John J. B., and Michael X. Cohen. “Deconstructing the ‘Resting’ State: Exploring the Temporal Dynamics of Frontal Alpha Asymmetry as an Endophenotype for Depression.” Frontiers in Human Neuroscience, vol. 4, 2010, https://www.frontiersin.org/articles/10.3389/fnhum.2010.00232/full

Bruder, Gerard E., et al. “EEG Alpha Asymmetry in Patients with Depression and Anxiety Disorders.” Biological Psychiatry, vol. 41, no. 9, 1997, pp. 914–28. https://psychophysiology.cpmc.columbia.edu/pdf/bruder1997a.pdf

Davidson, Richard J. “Cerebral Asymmetry, Emotion, and Affective Style.” In Brain Asymmetry, edited by Richard J. Davidson and Kenneth Hugdahl, MIT Press, 1995, pp. 361–87. https://mitpress.mit.edu/9780262041490/brain-asymmetry/

Figueroa, C., et al. “Quantitative Electroencephalography in the Neurocritical Care Unit: A Narrative Review.” Journal of Clinical Medicine, vol. 13, no. 11, 2024, p. 3199. https://www.researchgate.net/figure/The-relationship-of-cerebral-blood-flow-to-electroencephalogram-EEG-and-pathophysiology_fig2_221722486

Lai, Wing-Fu, and Wing-Tak Wong. “Design and Practical Considerations for Active Polymeric Films in Food Packaging.” International Journal of Molecular Sciences 23, no. 11 (2022): 6295.https://www.mdpi.com/1422-0067/23/11/6295.

McEwen, Bruce S. “In Pursuit of Resilience: Stress, Epigenetics, and Brain Plasticity.” Annals of the New York Academy of Sciences, vol. 1373, no. 1, 2016, pp. 56–64. https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/nyas.13020

Medscape. “EEG in Dementia.” Medscape Reference, Accessed April 28, 2025. https://emedicine.medscape.com/article/1138235-overview

National Center for Biotechnology Information. “Focal and Generalized Slowing and Significance.” In EEG Primer. Bethesda, MD: National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK390357/

Soutar, Richard. “QEEG Asymmetry as a Reliable Measure of Adult Anxiety and Depression.” NeuroRegulation, vol. 1, no. 1, 2013, pp. 83–99. https://nmindjournal.com/qeeg-asymmetry-as-a-reliable-measure-of-adult-anxiety-and-depression/

Soutar, Richard. “Oxidative Stress & qEEG Part 1.” YouTube, uploaded by NewMind Technologies, 1 Feb. 2016, https://youtu.be/RXb3nrGpnL8?si=eJSLVRqg6JloshGU

Velikova, S., et al. “Oxidative Stress in Neurodegenerative Diseases: Pathophysiology, Biomarkers, and Therapeutic Perspectives.” Antioxidants, vol. 13, no. 4, 2024, p. 431. https://www.mdpi.com/1424-8220/13/4/431

Yale University. “Lecture 21: Stress and the Brain.” The Human Brain (course website), Accessed April 28, 2025. https://campuspress.yale.edu/humanbrain/lecture-21/

Yokel, Robert A. “The Toxicology of Aluminum in the Brain: A Review.” Neurotoxicology, vol. 21, no. 5, 2000, pp. 813–28. https://pubmed.ncbi.nlm.nih.gov/11130287/

Zabłocka-Słowińska, Katarzyna, et al. “Oxidative Stress in Neurodegenerative Diseases.” International Journal of Molecular Sciences, vol. 23, no. 11, 2022, p. 6295. https://www.mdpi.com/1422-0067/23/11/6295

Zetterberg, Henrik, and Kaj Blennow. “EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer’s Disease.” Journal of Alzheimer’s Disease, vol. 64, no. 4, 2024, pp. 1133–43. https://pubmed.ncbi.nlm.nih.gov/29991135/